赛伦生物
(688163)
| 流通市值：25.97亿 | | | 总市值：25.97亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 175,138,574.09 | 100,819,362.78 | 25,621,279.55 | 194,915,924.94 |
| 营业收入 | 175,138,574.09 | 100,819,362.78 | 25,621,279.55 | 194,915,924.94 |
| 二、营业总成本 | 105,193,973.75 | 64,302,763.21 | 23,621,291.88 | 143,439,085.68 |
| 营业成本 | 37,782,811.72 | 22,843,412.63 | 6,449,803.93 | 42,770,555.87 |
| 税金及附加 | 1,533,115.66 | 966,354.3 | 368,076.83 | 1,795,252.05 |
| 销售费用 | 37,265,131.66 | 21,958,773.94 | 9,087,859.92 | 54,520,612.25 |
| 管理费用 | 17,150,832.68 | 11,127,520.58 | 4,935,368.47 | 22,186,727.9 |
| 研发费用 | 12,878,600.46 | 8,476,409.41 | 3,182,878.72 | 23,839,957.85 |
| 财务费用 | -1,416,518.43 | -1,069,707.65 | -402,695.99 | -1,674,020.24 |
| 其中:利息费用 | 124,633.23 | 84,036.12 | 42,018.06 | 430,189 |
| 其中:利息收入 | 1,440,745.79 | 1,037,643.75 | -448,795.13 | 2,161,838.76 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,297,780.82 | 1,868,602.74 | 1,001,068.49 | 1,207,523.29 |
| 加:投资收益 | 6,380,500.14 | 3,167,874.32 | 2,266,175.69 | 3,961,651.43 |
| 资产处置收益 | - | - | - | 1,446,155.63 |
| 资产减值损失(新) | -1,211,414.94 | -522,966.76 | -461,598.53 | -9,209,017.29 |
| 信用减值损失(新) | -1,878,459.12 | -3,542,092.5 | -661,213.96 | -485,439.3 |
| 其他收益 | 497,430.05 | 409,878.05 | 85,021.05 | 3,587,234.77 |
| 四、营业利润 | 75,030,437.29 | 37,897,895.42 | 4,229,440.41 | 51,984,947.79 |
| 加:营业外收入 | 170,776.04 | 90,409.71 | 90,409.71 | 5,463.01 |
| 减:营业外支出 | 383,743.93 | 223,047.46 | 151,951.06 | 1,424,357.61 |
| 五、利润总额 | 74,817,469.4 | 37,765,257.67 | 4,167,899.06 | 50,566,053.19 |
| 减:所得税费用 | 10,606,814.59 | 4,788,524.3 | 410,582.84 | 6,275,649.91 |
| 六、净利润 | 64,210,654.81 | 32,976,733.37 | 3,757,316.22 | 44,290,403.28 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 64,210,654.81 | 32,976,733.37 | 3,757,316.22 | 44,290,403.28 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 64,210,654.81 | 32,976,733.37 | 3,757,316.22 | 44,290,403.28 |
| 扣除非经常损益后的净利润 | 56,435,671.82 | 28,527,072.7 | -67,743.17 | 28,249,755.69 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.59 | 0.3 | 0.03 | 0.41 |
| (二)稀释每股收益 | 0.59 | 0.3 | 0.03 | 0.41 |
| 九、综合收益总额 | 64,210,654.81 | 32,976,733.37 | 3,757,316.22 | 44,290,403.28 |
| 归属于母公司股东的综合收益总额 | 64,210,654.81 | 32,976,733.37 | 3,757,316.22 | 44,290,403.28 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |